Alpha-Methylacyl Coenzyme A Racemase (aMACR) Antibody

Este producto es parte de AMACR - Alpha-methylacyl-CoA racemase
Alpha-Methylacyl Coenzyme A Racemase (aMACR) Antibody
286€ (100 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

Name
Alpha-Methylacyl Coenzyme A Racemase (aMACR) Antibody
Category
Primary Antibodies
Provider
Abbexa
Reference
abx131531
Tested Applications
WB, IHC

Description

aMACR Antibody is a Rabbit Polyclonal against aMACR.

Documentos del producto

Instrucciones
Data sheet
Descargar

Especificaciones del producto

Category
Primary Antibodies
Immunogen Target
Target: Alpha-Methylacyl Coenzyme A Racemase (aMACR)
Immunogen: aMACR (Ala2-Asn148)
Host
Rabbit
Reactivity
Human
Recommended Dilution
WB: 0.01-2 µg/ml, IHC: 5-20 µg/ml, IF/ICC (Predicted): 5-20 µg/ml. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Purification
Purified by antigen-specific affinity chromatography, followed by Protein A affinity chromatography.
Size 1
100 µl
Size 2
200 µl
Size 3
1 ml
Form
Liquid
Tested Applications
WB, IHC
Buffer
0.01 M PBS, pH 7.4, containing 0.05% Proclin-300, 50% glycerol.
Availability
Shipped within 5-7 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
Q9UHK6
Alias
AMACR
Background
Antibody anti-AMACR
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.

Background

Alpha-Methylacyl-CoA Racemase (AMACR) is a mitochondrial and peroxisomal enzyme that catalyzes the racemization of alpha-methyl-branched fatty acid derivatives and bile acid intermediates, enabling their further metabolism via beta-oxidation. AMACR is critical in lipid metabolism, particularly in the breakdown of dietary branched-chain fatty acids and the processing of bile acids derived from cholesterol. It is highly expressed in tissues with active fatty acid metabolism, such as the liver and kidneys. Dysregulation or mutations in the AMACR gene are associated with metabolic disorders, including adult-onset sensory neuropathy and bile acid metabolism defects. Additionally, AMACR is a well-established biomarker for prostate cancer and other malignancies, as its overexpression is linked to cancer cell metabolism and tumor progression. Targeting AMACR enzymatic activity is being explored as a therapeutic strategy in cancer and metabolic disorders.

Productos relacionados

abx001044

Alpha-Methylacyl-CoA Racemase (AMACR) Antibody

AMACR Antibody is a Rabbit Polyclonal antibody against AMACR. This gene encodes a racemase. The encoded enzyme interconv…

Ver producto
abx015770

Alpha-Methylacyl-CoA Racemase (AMACR) Antibody

AMACR (alpha-methylacyl-CoA racemase) has been recently described as prostate cancer-specific gene that encodes a protei…

Ver producto
abx025595

Alpha-Methylacyl-CoA Racemase (AMACR) Antibody

This gene encodes a racemase. The encoded enzyme interconverts pristanoyl-CoA and C27-bile acylCoAs between their (R) an…

Ver producto